Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Retained Earnings (2016 - 2025)

Dexcom (DXCM) has disclosed Retained Earnings for 16 consecutive years, with $115.0 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 92.8% to $115.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $115.0 million through Dec 2025, down 92.8% year-over-year, with the annual reading at $115.0 million for FY2025, 92.8% down from the prior year.
  • Retained Earnings for Q4 2025 was $115.0 million at Dexcom, down from $2.2 billion in the prior quarter.
  • The five-year high for Retained Earnings was $2.2 billion in Q3 2025, with the low at -$98.9 million in Q2 2021.
  • Average Retained Earnings over 5 years is $332.8 million, with a median of $2.6 million recorded in 2021.
  • Peak annual rise in Retained Earnings hit 9666.47% in 2024, while the deepest fall reached 473.85% in 2024.
  • Over 5 years, Retained Earnings stood at $138.7 million in 2021, then surged by 246.0% to $479.9 million in 2022, then plummeted by 103.48% to -$16.7 million in 2023, then surged by 9666.47% to $1.6 billion in 2024, then crashed by 92.8% to $115.0 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at $115.0 million, $2.2 billion, and $83.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.